Source comparison
The Blunt Truth About CJC-1295 Versus Other Research Peptides
Here's the honest answer: most researchers choose CJC-1295 for convenience, not because it's mechanistically superior to other peptides. The once-weekly dosing eliminates the logistical burden of multiple daily injections, which matters enormously in longitudi
This comparison does not assign a generated winner or score.
- Here's the honest answer: most researchers choose CJC-1295 for convenience, not because it's mechanistically superior to other peptides. The once-weekly dosing eliminates the logistical burden of multiple daily injections, which matters enormously in longitudinal studies or models with large cohorts. But convenience doesn't mean better science. If your research question examines acute GH dynamics, receptor pulsatility, or appetite-GH interactions, CJC-1295's sustained-release profile obscures the very phenomena you're trying to measure. The albumin-binding modification that makes it convenient also flattens the physiological waveform.
- GHRP-2 produces 3–5× higher peak GH levels than CJC-1295 in head-to-head studies, but those peaks vanish within hours. Hexarelin hits even harder but desensitises receptors faster than any other compound in the class. Ipamorelin offers the cleanest ghrelin receptor selectivity with minimal prolactin or cortisol elevation. Critical when those hormones would confound your dependent variables. There's no universal